Objectives: Over the last decades, there has been a significant increase in antimicrobial
prescribing and consumption associated with the development of patients' adverse events …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Background Most patients with COVID-19 receive antibiotics despite the fact that bacterial co-
infections are rare. This can lead to increased complications, including antibacterial …

Background: Literature suggests that antibiotic prescribing in COVID-19 patients is high.
Currently, there are insufficient data on what drives antibiotic prescribing practices …

The emergence of COVID-19 infection led to the indiscriminate use of antimicrobials without
knowing their efficacy in treating the disease. The gratuitous use of antibiotics for COVID-19 …

This scoping review provides new evidence on the prevalence and patterns of global
antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used …

Background Antibiotics may be indicated in patients with COVID-19 due to suspected or
confirmed bacterial superinfection. Objectives To investigate antibiotic prescribing practices …

This scoping review aimed to explore the prevalence and patterns of global antibiotic use
and bacterial infection in COVID-19 patients from studies published between June 2020 and …

COVID-19 is caused by the SARS-CoV-2 virus, which has infected more than 4 million
people with 278 892 deaths worldwide as of 11 May 2020. This disease, which can manifest …

Hospitalized patients with SARS-CoV-2 infection (COVID-19) often receive antibiotics for
suspected bacterial coinfection. We estimated the incidence of bacterial coinfection and …